Skip to main content
Erschienen in: Cancer Causes & Control 3/2013

01.03.2013 | Brief report

Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4

verfasst von: Max Leenders, Samsiddhi Bhattacharjee, Paolo Vineis, Victoria Stevens, H. Bas Bueno-de-Mesquita, Xiao-Ou Shu, Laufey Amundadottir, Myron Gross, Geoffrey S. Tobias, Jean Wactawski-Wende, Alan A. Arslan, Eric J. Duell, Charles S. Fuchs, Steven Gallinger, Patricia Hartge, Robert N. Hoover, Elizabeth A. Holly, Eric J. Jacobs, Alison P. Klein, Charles Kooperberg, Andrea LaCroix, Donghui Li, Margaret T. Mandelson, Sara H. Olson, Gloria Petersen, Harvey A. Risch, Kai Yu, Brian M. Wolpin, Wei Zheng, Ilir Agalliu, Demetrius Albanes, Marie-Christine Boutron-Ruault, Paige M. Bracci, Julie E. Buring, Federico Canzian, Kenneth Chang, Stephen J. Chanock, Michelle Cotterchio, J. Michael Gaziano, Edward L. Giovanucci, Michael Goggins, Göran Hallmans, Susan E. Hankinson, Judith A. Hoffman-Bolton, David J. Hunter, Amy Hutchinson, Kevin B. Jacobs, Mazda Jenab, Kay-Tee Khaw, Peter Kraft, Vittorio Krogh, Robert C. Kurtz, Robert R. McWilliams, Julie B. Mendelsohn, Alpa V. Patel, Kari G. Rabe, Elio Riboli, Anne Tjønneland, Dimitrios Trichopoulos, Jarmo Virtamo, Kala Visvanathan, Joanne W. Elena, Herbert Yu, Anne Zeleniuch-Jacquotte, Rachael Z. Stolzenberg-Solomon

Erschienen in: Cancer Causes & Control | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The evidence of a relation between folate intake and one-carbon metabolism (OCM) with pancreatic cancer (PanCa) is inconsistent. In this study, the association between genes and single-nucleotide polymorphisms (SNPs) related to OCM and PanCa was assessed.

Methods

Using biochemical knowledge of the OCM pathway, we identified thirty-seven genes and 834 SNPs to examine in association with PanCa. Our study included 1,408 cases and 1,463 controls nested within twelve cohorts (PanScan). The ten SNPs and five genes with lowest p values (<0.02) were followed up in 2,323 cases and 2,340 controls from eight case–control studies (PanC4) that participated in PanScan2. The correlation of SNPs with metabolite levels was assessed for 649 controls from the European Prospective Investigation into Cancer and Nutrition.

Results

When both stages were combined, we observed suggestive associations with PanCa for rs10887710 (MAT1A) (OR 1.13, 95 %CI 1.04–1.23), rs1552462 (SYT9) (OR 1.27, 95 %CI 1.02–1.59), and rs7074891 (CUBN) (OR 1.91, 95 %CI 1.12–3.26). After correcting for multiple comparisons, no significant associations were observed in either the first or second stage. The three suggested SNPs showed no correlations with one-carbon biomarkers.

Conclusions

This is the largest genetic study to date to examine the relation between germline variations in OCM-related genes polymorphisms and the risk of PanCa. Suggestive evidence for an association between polymorphisms and PanCa was observed among the cohort-nested studies, but this did not replicate in the case–control studies. Our results do not strongly support the hypothesis that genes related to OCM play a role in pancreatic carcinogenesis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21(35):5400–5413PubMedCrossRef Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21(35):5400–5413PubMedCrossRef
2.
Zurück zum Zitat Tibbetts AS, Appling DR (2010) Compartmentalization of Mammalian folate-mediated one-carbon metabolism. Annu Rev Nutr 30:57–81PubMedCrossRef Tibbetts AS, Appling DR (2010) Compartmentalization of Mammalian folate-mediated one-carbon metabolism. Annu Rev Nutr 30:57–81PubMedCrossRef
3.
Zurück zum Zitat Liu JJ, Ward RL (2010) Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer. Adv Genet 71:79–121PubMedCrossRef Liu JJ, Ward RL (2010) Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer. Adv Genet 71:79–121PubMedCrossRef
4.
Zurück zum Zitat Larsson SC, Orsini N, Wolk A (2010) Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 303(11):1077–1083PubMedCrossRef Larsson SC, Orsini N, Wolk A (2010) Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 303(11):1077–1083PubMedCrossRef
5.
Zurück zum Zitat Kim D-H, Smith-Warner SA, Spiegelman D et al (2010) Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 21(11):1919–1930PubMedCrossRef Kim D-H, Smith-Warner SA, Spiegelman D et al (2010) Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 21(11):1919–1930PubMedCrossRef
6.
Zurück zum Zitat Collin SM, Metcalfe C, Refsum H et al (2010) Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 19(6):1632–1642PubMedCrossRef Collin SM, Metcalfe C, Refsum H et al (2010) Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 19(6):1632–1642PubMedCrossRef
7.
Zurück zum Zitat Larsson SC, Giovannucci E, Wolk A (2007) Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99(1):64–76PubMedCrossRef Larsson SC, Giovannucci E, Wolk A (2007) Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99(1):64–76PubMedCrossRef
8.
Zurück zum Zitat Kim YI (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10(2):66–88PubMedCrossRef Kim YI (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10(2):66–88PubMedCrossRef
9.
Zurück zum Zitat Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM (1991) A case-control study of diet and cancer of the pancreas. Am J Epidemiol 134(2):167–179PubMed Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM (1991) A case-control study of diet and cancer of the pancreas. Am J Epidemiol 134(2):167–179PubMed
10.
Zurück zum Zitat Bravi F, Polesel J, Bosetti C et al (2011) Dietary intake of selected micronutrients and the risk of pancreatic cancer: an Italian case-control study. Ann Oncol 22(1):202–206PubMedCrossRef Bravi F, Polesel J, Bosetti C et al (2011) Dietary intake of selected micronutrients and the risk of pancreatic cancer: an Italian case-control study. Ann Oncol 22(1):202–206PubMedCrossRef
11.
Zurück zum Zitat Gong Z, Holly EA, Bracci PM (2009) Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control 20(8):1317–1325PubMedCrossRef Gong Z, Holly EA, Bracci PM (2009) Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control 20(8):1317–1325PubMedCrossRef
12.
Zurück zum Zitat Larsson SC, Håkansson N, Giovannucci E, Wolk A (2006) Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 98(6):407–413PubMedCrossRef Larsson SC, Håkansson N, Giovannucci E, Wolk A (2006) Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 98(6):407–413PubMedCrossRef
13.
Zurück zum Zitat Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, Stolzenberg-Solomon RZ (2010) Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 91(2):449–455PubMedCrossRef Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, Stolzenberg-Solomon RZ (2010) Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 91(2):449–455PubMedCrossRef
14.
Zurück zum Zitat Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, Taylor PR, Virtamo J, Albanes D (2001) Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol 153(7):680–687PubMedCrossRef Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, Taylor PR, Virtamo J, Albanes D (2001) Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol 153(7):680–687PubMedCrossRef
15.
Zurück zum Zitat Silverman DT, Swanson CA, Gridley G et al (1998) Dietary and nutritional factors and pancreatic cancer: a case–control study based on direct interviews. J Natl Cancer Inst 90(22):1710–1719PubMedCrossRef Silverman DT, Swanson CA, Gridley G et al (1998) Dietary and nutritional factors and pancreatic cancer: a case–control study based on direct interviews. J Natl Cancer Inst 90(22):1710–1719PubMedCrossRef
16.
Zurück zum Zitat Keszei AP, Verhage BAJ, Heinen MM, Goldbohm RA, van den Brandt PA (2009) Dietary folate and folate vitamers and the risk of pancreatic cancer in the Netherlands cohort study. Cancer Epidemiol Biomarkers Prev 18(6):1785–1791PubMedCrossRef Keszei AP, Verhage BAJ, Heinen MM, Goldbohm RA, van den Brandt PA (2009) Dietary folate and folate vitamers and the risk of pancreatic cancer in the Netherlands cohort study. Cancer Epidemiol Biomarkers Prev 18(6):1785–1791PubMedCrossRef
17.
Zurück zum Zitat Larsson SC, Giovannucci E, Wolk A (2006) Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131(4):1271–1283PubMedCrossRef Larsson SC, Giovannucci E, Wolk A (2006) Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131(4):1271–1283PubMedCrossRef
18.
Zurück zum Zitat Ohnami S, Sato Y, Yoshimura K et al (2008) His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk. Gastroenterology 135(2):477–488PubMedCrossRef Ohnami S, Sato Y, Yoshimura K et al (2008) His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk. Gastroenterology 135(2):477–488PubMedCrossRef
19.
Zurück zum Zitat Amundadottir L, Kraft P, Stolzenberg-Solomon RZ et al (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41(9):986–990PubMedCrossRef Amundadottir L, Kraft P, Stolzenberg-Solomon RZ et al (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41(9):986–990PubMedCrossRef
20.
Zurück zum Zitat Diergaarde B, Brand R, Lamb J et al (2010) Pooling-based genome-wide association study implicates gamma-glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesis. Pancreatology 10(2–3):194–200PubMedCrossRef Diergaarde B, Brand R, Lamb J et al (2010) Pooling-based genome-wide association study implicates gamma-glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesis. Pancreatology 10(2–3):194–200PubMedCrossRef
21.
Zurück zum Zitat Low S-K, Kuchiba A, Zembutsu H et al (2010) Genome-wide association study of pancreatic cancer in Japanese population. PLoS ONE 5(7):e11824PubMedCrossRef Low S-K, Kuchiba A, Zembutsu H et al (2010) Genome-wide association study of pancreatic cancer in Japanese population. PLoS ONE 5(7):e11824PubMedCrossRef
22.
Zurück zum Zitat Petersen GM, Amundadottir L, Fuchs CS et al (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42(3):224–228PubMedCrossRef Petersen GM, Amundadottir L, Fuchs CS et al (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42(3):224–228PubMedCrossRef
23.
Zurück zum Zitat Willis JA, Olson SH, Orlow I et al (2012) A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Res 18(14):3942–3951PubMedCrossRef Willis JA, Olson SH, Orlow I et al (2012) A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Res 18(14):3942–3951PubMedCrossRef
24.
Zurück zum Zitat Wu C, Miao X, Huang L et al (2012) Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet 44(1):62–66CrossRef Wu C, Miao X, Huang L et al (2012) Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet 44(1):62–66CrossRef
25.
Zurück zum Zitat Tanaka T, Scheet P, Giusti B et al (2009) Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet 84(4):477–482PubMedCrossRef Tanaka T, Scheet P, Giusti B et al (2009) Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet 84(4):477–482PubMedCrossRef
26.
Zurück zum Zitat Lange LA, Croteau-Chonka DC, Marvelle AF et al (2010) Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults. Hum Mol Genet 19(10):2050–2058PubMedCrossRef Lange LA, Croteau-Chonka DC, Marvelle AF et al (2010) Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults. Hum Mol Genet 19(10):2050–2058PubMedCrossRef
27.
Zurück zum Zitat Hazra A, Kraft P, Lazarus R et al (2009) Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet 18(23):4677–4687PubMedCrossRef Hazra A, Kraft P, Lazarus R et al (2009) Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet 18(23):4677–4687PubMedCrossRef
28.
Zurück zum Zitat Midttun Ø, Hustad S, Ueland PM (2009) Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 23(9):1371–1379PubMedCrossRef Midttun Ø, Hustad S, Ueland PM (2009) Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 23(9):1371–1379PubMedCrossRef
29.
Zurück zum Zitat Westfall PH, Young SS (1993) Resampling-based multiple testing: examples and methods for p-value adjustment. Wiley, New York, NY Westfall PH, Young SS (1993) Resampling-based multiple testing: examples and methods for p-value adjustment. Wiley, New York, NY
30.
Zurück zum Zitat Yu K, Li Q, Bergen AW et al (2009) Pathway analysis by adaptive combination of P-values. Genet Epidemiol 33(8):700–709PubMedCrossRef Yu K, Li Q, Bergen AW et al (2009) Pathway analysis by adaptive combination of P-values. Genet Epidemiol 33(8):700–709PubMedCrossRef
31.
Zurück zum Zitat Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57(1):289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57(1):289–300
32.
Zurück zum Zitat Chuang S-C, Stolzenberg-Solomon R, Ueland PM et al (2011) A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer 47(12):1808–1816PubMedCrossRef Chuang S-C, Stolzenberg-Solomon R, Ueland PM et al (2011) A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer 47(12):1808–1816PubMedCrossRef
Metadaten
Titel
Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4
verfasst von
Max Leenders
Samsiddhi Bhattacharjee
Paolo Vineis
Victoria Stevens
H. Bas Bueno-de-Mesquita
Xiao-Ou Shu
Laufey Amundadottir
Myron Gross
Geoffrey S. Tobias
Jean Wactawski-Wende
Alan A. Arslan
Eric J. Duell
Charles S. Fuchs
Steven Gallinger
Patricia Hartge
Robert N. Hoover
Elizabeth A. Holly
Eric J. Jacobs
Alison P. Klein
Charles Kooperberg
Andrea LaCroix
Donghui Li
Margaret T. Mandelson
Sara H. Olson
Gloria Petersen
Harvey A. Risch
Kai Yu
Brian M. Wolpin
Wei Zheng
Ilir Agalliu
Demetrius Albanes
Marie-Christine Boutron-Ruault
Paige M. Bracci
Julie E. Buring
Federico Canzian
Kenneth Chang
Stephen J. Chanock
Michelle Cotterchio
J. Michael Gaziano
Edward L. Giovanucci
Michael Goggins
Göran Hallmans
Susan E. Hankinson
Judith A. Hoffman-Bolton
David J. Hunter
Amy Hutchinson
Kevin B. Jacobs
Mazda Jenab
Kay-Tee Khaw
Peter Kraft
Vittorio Krogh
Robert C. Kurtz
Robert R. McWilliams
Julie B. Mendelsohn
Alpa V. Patel
Kari G. Rabe
Elio Riboli
Anne Tjønneland
Dimitrios Trichopoulos
Jarmo Virtamo
Kala Visvanathan
Joanne W. Elena
Herbert Yu
Anne Zeleniuch-Jacquotte
Rachael Z. Stolzenberg-Solomon
Publikationsdatum
01.03.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 3/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0138-0

Weitere Artikel der Ausgabe 3/2013

Cancer Causes & Control 3/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.